Daniel Starczynowski
8Patents
4h-index
9Co-inventors
42Inventor score
Filing activity: May 22, 2014 → Nov 21, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9855273B2 | Combination therapy for MDS | Chemistry; Metallurgy | 13 | Active |
| US9168257B2 | Combination therapy for MDS | Chemistry; Metallurgy | 12 | Active |
| US9504706B2 | Combination therapy for MDS | Chemistry; Metallurgy | 5 | Active |
| US11542261B2 | Substituted Imidazo[1,2-a]-pyridines as IRAK 1/4 and FLT3 inhibitors | Human Necessities | 4 | Active |
| US11547696B2 | Methods and compositions for treatment of myelodysplastic syndromes and/or acute myeloid leukemias | Human Necessities | 1 | Active |
| US11752136B2 | Methods and compositions for treatment of myelodysplastic syndromes and/or acute myeloid leukemias | Human Necessities | 0 | Active |
| US10487329B2 | Methods and compositions for the treatment of head and neck cancer | Chemistry; Metallurgy | 0 | Active |
| US11254667B2 | Substituted imidazo[1,2-A]pyridines as IRAK 1/4 and flt3 inhibitors | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.